Biodesix, Inc. Sustainability Profile
Biodesix, Inc., a leading player in the precision medicine industry, is headquartered in the United States. Founded in 2010, the company has made significant strides in the development of innovative diagnostic solutions, particularly in the field of lung cancer. Biodesix focuses on utilising advanced genomic and proteomic technologies to provide actionable insights for oncologists, enhancing patient care through personalised treatment options. The company’s core offerings include its proprietary blood-based tests, which are designed to identify specific biomarkers associated with lung cancer. This unique approach not only aids in early detection but also helps in tailoring therapies to individual patient profiles. Biodesix has established a strong market position, recognised for its commitment to improving patient outcomes and advancing the field of oncology diagnostics.
DitchCarbon Score
How does Biodesix, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biodesix, Inc.'s score of 28 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biodesix, Inc.'s reported carbon emissions
Biodesix, Inc., headquartered in the United States, is committed to addressing climate change through various initiatives, although specific carbon emissions data is currently unavailable. The company has made a near-term commitment to reduce its carbon footprint, aligning with industry standards for sustainability. As of April 17, 2025, Biodesix is classified as "Committed" to near-term reduction targets, although specific numerical targets have not been disclosed. The company operates within the Healthcare Providers and Services and Healthcare Technology sector, indicating a focus on sustainable practices in a critical industry. Biodesix has not inherited emissions data from any parent company, ensuring that its climate commitments are independently defined. The absence of specific emissions figures highlights the need for ongoing transparency and accountability in their environmental impact reporting. Overall, Biodesix, Inc. is taking steps towards sustainability, with a clear commitment to future emissions reductions, although detailed metrics are yet to be established.
How Carbon Intensive is Biodesix, Inc.'s Industry?
How Carbon Intensive is Biodesix, Inc.'s Location?
Biodesix, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biodesix, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
